Reactive Astrocytes As Therapeutic Targets for CNS Disorders

Barres, 2008, The mystery and magic of glia: a perspective on their roles in health and disease, Neuron, 60, 430, 10.1016/j.neuron.2008.10.013

Nedergaard, 2003, New roles for astrocytes: redefining the functional architecture of the brain, Trends Neurosci, 26, 523, 10.1016/j.tins.2003.08.008

Pellerin, 2007, Activity-dependent regulation of energy metabolism by astrocytes: an update, Glia, 55, 1251, 10.1002/glia.20528

Seifert, 2006, Astrocyte dysfunction in neurological disorders: a molecular perspective, Nat Rev Neurosci, 7, 194, 10.1038/nrn1870

Sofroniew, 2010, Astrocytes: biology and pathology, Acta Neuropathol, 119, 7, 10.1007/s00401-009-0619-8

Pekny, 2005, Astrocyte activation and reactive gliosis, Glia, 50, 427, 10.1002/glia.20207

Sofroniew, 2009, Molecular dissection of reactive astrogliosis and glial scar formation, Trends Neurosci, 32, 638, 10.1016/j.tins.2009.08.002

Sofroniew, 2005, Reactive astrocytes in neural repair and protection, Neuroscientist, 5, 400, 10.1177/1073858405278321

Darlington, 2005, Astrocytes as targets for neuroprotective drugs, Curr Opin Investig Drugs, 6, 700

Fuller, 2009, Activated astrocytes: a therapeutic target in Alzheimer's disease?, Expert Rev Neurother, 9, 1585, 10.1586/ern.09.111

Sofroniew, 2000, Astrocyte failure as a cause of CNS dysfunction, Mol Psychiatry, 5, 230, 10.1038/sj.mp.4000753

Rothstein, 1996, Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate, Neuron, 16, 675, 10.1016/S0896-6273(00)80086-0

Bush, 1999, Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice, Neuron, 23, 297, 10.1016/S0896-6273(00)80781-3

Swanson, 2004, Astrocyte influences on ischemic neuronal death, Curr Mol Med, 4, 193, 10.2174/1566524043479185

Chen, 2001, Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism, J Neurochem, 77, 1601, 10.1046/j.1471-4159.2001.00374.x

Shih, 2003, Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress, J Neurosci, 23, 3394, 10.1523/JNEUROSCI.23-08-03394.2003

Vargas, 2008, Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis, J Neurosci, 28, 13574, 10.1523/JNEUROSCI.4099-08.2008

Sarafian, 2010, Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro, PLoS One, 5, e9532, 10.1371/journal.pone.0009532

Lin, 2008, A central role of connexin 43 in hypoxic preconditioning, J Neurosci, 28, 681, 10.1523/JNEUROSCI.3827-07.2008

Rao, 2005, Astrocytes protect neurons from ammonia toxicity, Neurochem Res, 30, 1311, 10.1007/s11064-005-8803-2

Koistinaho, 2004, Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides, Nat Med, 10, 719, 10.1038/nm1058

Zador, 2009, Role of aquaporin-4 in cerebral edema and stroke, Handb Exp Pharmacol, 190, 159, 10.1007/978-3-540-79885-9_7

Faulkner, 2004, Reactive astrocytes protect tissue and preserve function after spinal cord injury, J Neurosci, 24, 2143, 10.1523/JNEUROSCI.3547-03.2004

Myer, 2006, Essential protective roles of reactive astrocytes in traumatic brain injury, Brain, 129, 2761, 10.1093/brain/awl165

Herrmann, 2008, STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury, J Neurosci, 28, 7231, 10.1523/JNEUROSCI.1709-08.2008

Li, 2008, Protective role of reactive astrocytes in brain ischemia, J Cereb Blood Flow Metab, 28, 468, 10.1038/sj.jcbfm.9600546

Okada, 2006, Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury, Nat Med, 12, 829, 10.1038/nm1425

Drogemuller, 2008, Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis, J Immunol, 181, 2683, 10.4049/jimmunol.181.4.2683

Voskuhl, 2009, Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS, J Neurosci, 29, 11511, 10.1523/JNEUROSCI.1514-09.2009

Maragakis, 2006, Mechanisms of disease: astrocytes in neurodegenerative disease, Nat Clin Pract Neurol, 2, 679, 10.1038/ncpneuro0355

Sattler, 2006, Regulation and dysregulation of glutamate transporters, Handb Exp Pharmacol, 277, 10.1007/3-540-29784-7_14

Dabir, 2006, Impaired glutamate transport in a mouse model of tau pathology in astrocytes, J Neurosci, 26, 644, 10.1523/JNEUROSCI.3861-05.2006

Li, 2006, Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype, J Neurochem, 97, 759, 10.1111/j.1471-4159.2006.03743.x

Rothstein, 1992, Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis, N Engl J Med, 326, 1464, 10.1056/NEJM199205283262204

Fontana, 2007, Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom, Mol Pharmacol, 72, 1228, 10.1124/mol.107.037127

Fontana, 2003, Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake, Br J Pharmacol, 139, 1297, 10.1038/sj.bjp.0705352

Rothstein, 2005, β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression, Nature, 433, 73, 10.1038/nature03180

Pascuzzi, 2010, A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis, Amyotroph Lateral Scler, 11, 266, 10.3109/17482960903307805

Cornell-Bell, 1990, Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling, Science, 247, 470, 10.1126/science.1967852

Wang, 2009, Astrocytic calcium signaling: mechanism and implications for functional brain imaging, Methods Mol Biol, 489, 93, 10.1007/978-1-59745-543-5_5

Shigetomi, 2010, A genetically targeted optical sensor to monitor calcium signals in astrocyte processes, Nat Neurosci, 13, 759, 10.1038/nn.2557

Halassa, 2010, Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior, Annu Rev Physiol, 72, 335, 10.1146/annurev-physiol-021909-135843

Henneberger, 2010, Long-term potentiation depends on release of d-serine from astrocytes, Nature, 463, 232, 10.1038/nature08673

Shigetomi, 2008, Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons, J Neurosci, 28, 6659, 10.1523/JNEUROSCI.1717-08.2008

Hamby, 2008, TGF-β1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner, Prostaglandins Other Lipid Mediat, 85, 115, 10.1016/j.prostaglandins.2007.11.004

Hewett, 1994, Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS, Neuron, 13, 487, 10.1016/0896-6273(94)90362-X

Katsuse, 2003, Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies, Neuropathology, 23, 9, 10.1046/j.1440-1789.2003.00483.x

Lieb, 2003, Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells, Neurochem Int, 42, 131, 10.1016/S0197-0186(02)00076-1

Tran, 1997, Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis, J Neuroimmunol, 74, 121, 10.1016/S0165-5728(96)00215-9

Liberatore, 1999, Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat Med, 5, 1403, 10.1038/70978

Pozza, 2000, Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution, Brain Res, 855, 39, 10.1016/S0006-8993(99)02133-2

Smith, 2002, The role of nitric oxide in multiple sclerosis, Lancet Neurol, 1, 232, 10.1016/S1474-4422(02)00102-3

Iadecola, 1997, Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, J Neurosci, 17, 9157, 10.1523/JNEUROSCI.17-23-09157.1997

Iadecola, 1995, Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage, Am J Physiol, 268, R286

Shin, 2000, Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord, Immunol Invest, 29, 233, 10.3109/08820130009060864

Shin, 1998, An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats, J Neuroimmunol, 92, 133, 10.1016/S0165-5728(98)00194-5

Iadecola, 1995, Nitric oxide contributes to functional hyperemia in cerebellar cortex, Am J Physiol, 268, R1153

Nathan, 2005, Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase, J Exp Med, 202, 1163, 10.1084/jem.20051529

Lei, 1992, Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex, Neuron, 8, 1087, 10.1016/0896-6273(92)90130-6

Colton, 2006, NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease, Proc Natl Acad Sci U S A, 103, 12867, 10.1073/pnas.0601075103

Lipton, 1993, A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature, 364, 626, 10.1038/364626a0

Vidwans, 1999, Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture, J Neurochem, 72, 1843, 10.1046/j.1471-4159.1999.0721843.x

Szabo, 1996, DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite, Proc Natl Acad Sci U S A, 93, 1753, 10.1073/pnas.93.5.1753

Zingarelli, 1996, Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide, J Immunol, 156, 350, 10.4049/jimmunol.156.1.350

Hewett, 1996, Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS, Stroke, 27, 1586, 10.1161/01.STR.27.9.1586

Vidwans, 2004, Enhanced release of synaptic glutamate underlies the potentiation of oxygen-glucose deprivation-induced neuronal injury after induction of NOS-2, Exp Neurol, 190, 91, 10.1016/j.expneurol.2004.06.018

Koehler, 2009, Astrocytes and the regulation of cerebral blood flow, Trends Neurosci, 32, 160, 10.1016/j.tins.2008.11.005

Barber, 2010, Oxidative stress in ALS: key role in motor neuron injury and therapeutic target, Free Radic Biol Med, 48, 629, 10.1016/j.freeradbiomed.2009.11.018

Ilieva, 2009, Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond, J Cell Biol, 187, 761, 10.1083/jcb.200908164

Yamanaka, 2008, Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis, Nat Neurosci, 11, 251, 10.1038/nn2047

Rothstein, 1995, Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis, Ann Neurol, 38, 73, 10.1002/ana.410380114

Bruijn, 1997, ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1–containing inclusions, Neuron, 18, 327, 10.1016/S0896-6273(00)80272-X

Lepore, 2008, Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease, Nat Neurosci, 11, 1294, 10.1038/nn.2210

Lleo, 2007, Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases, Cell Mol Life Sci, 64, 1403, 10.1007/s00018-007-6516-1

Asanuma, 2006, Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation, Expert Rev Neurotherapeutics, 6, 1313, 10.1586/14737175.6.9.1313

Heneka, 2005, Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice, Brain, 128, 1442, 10.1093/brain/awh452

Drachman, 2002, Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS, Ann Neurol, 52, 771, 10.1002/ana.10374

Bae, 2006, Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells, Biochim Biophys Acta, 1763, 282, 10.1016/j.bbamcr.2006.01.005

Dringen, 2003, Glutathione pathways in the brain, Biol Chem, 384, 505, 10.1515/BC.2003.059

Bush, 1998, Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice, Cell, 93, 189, 10.1016/S0092-8674(00)81571-8

Savidge, 2007, Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione, Gastroenterology, 132, 1344, 10.1053/j.gastro.2007.01.051

Hamby, 2006, TGF-β1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2, Glia, 54, 566, 10.1002/glia.20411

Hewett, 1999, Interferon-gamma reduces cyclooxygenase-2-mediated prostaglandin E2 production from primary mouse astrocytes independent of nitric oxide formation, J Neuroimmunol, 94, 134, 10.1016/S0165-5728(98)00240-9

Hewett, 1993, Interferon-gamma and interleukin-1 β induce nitric oxide formation from primary mouse astrocytes, Neurosci Lett, 164, 229, 10.1016/0304-3940(93)90898-U

Hamby, 2008, TGFβ1 and TNFα potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2, Neurochem Int, 52, 962, 10.1016/j.neuint.2007.10.010

Minghetti, 1998, Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-β1 and interleukin 10 in activated microglial cultures, J Neuroimmunol, 82, 31, 10.1016/S0165-5728(97)00185-9

Saad, 1991, Astrocyte-derived TGF-β2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes, J Cell Biol, 115, 473, 10.1083/jcb.115.2.473

Krieglstein, 1998, Short communication: transforming growth factor-β mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons, Eur J Neurosci, 10, 2746

Villoslada, 2004, Role of nerve growth factor and other trophic factors in brain inflammation, Prog Brain Res, 146, 403, 10.1016/S0079-6123(03)46025-1

Ridet, 1997, Reactive astrocytes: cellular and molecular cues to biological function, Trends Neurosci, 20, 570, 10.1016/S0166-2236(97)01139-9

Mena, 2008, Glial cells as players in parkinsonism: the “good,” the “bad,” and the “mysterious” glia, Neuroscientist, 14, 544, 10.1177/1073858408322839

Ishibashi, 2006, Astrocytes promote myelination in response to electrical impulses, Neuron, 49, 823, 10.1016/j.neuron.2006.02.006

Lindholm, 1992, Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation, J Cell Biol, 117, 395, 10.1083/jcb.117.2.395

Wang, 1995, Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia, Brain Res Bull, 36, 607, 10.1016/0361-9230(94)00243-T

Krupinski, 1996, Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans, Stroke, 27, 852, 10.1161/01.STR.27.5.852

Ata, 1997, Expression of various TGF-β isoforms and type I receptor in necrotizing human brain lesions, Acta Neuropathol, 93, 326, 10.1007/s004010050623

Ali, 2001, Increased expression of transforming growth factor-β after cerebral ischemia in the baboon: an endogenous marker of neuronal stress?, J Cereb Blood Flow Metab, 21, 820, 10.1097/00004647-200107000-00007

Zetterberg, 2004, Increased cerebrospinal fluid levels of transforming growth factor-β1 in Alzheimer's disease, Neurosci Lett, 367, 194, 10.1016/j.neulet.2004.06.001

Kiefer, 1995, Transforming growth factor-β1: a lesion-associated cytokine of the nervous system, Int J Dev Neurosci, 13, 331, 10.1016/0736-5748(94)00074-D

Kiefer, 1993, Interleukin-6 and transforming growth factor-β1 mRNAs are induced in rat facial nucleus following motoneuron axotomy, Eur J Neurosci, 5, 775, 10.1111/j.1460-9568.1993.tb00929.x

Knuckey, 1996, Differential neuronal and astrocytic expression of transforming growth factor β isoforms in rat hippocampus following transient forebrain ischemia, Brain Res Mol Brain Res, 40, 1

Morgan, 1993, TGF-β1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration, Exp Neurol, 120, 291, 10.1006/exnr.1993.1063

Wahl, 1991, Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome, J Exp Med, 173, 981, 10.1084/jem.173.4.981

Krupinski, 1998, Inducible nitric oxide production and expression of transforming growth factor-β1 in serum and CSF after cerebral ischaemic stroke in man, Nitric Oxide, 2, 442, 10.1006/niox.1998.0204

Morganti-Kossmann, 1999, TGF-β is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood–brain barrier function, J Neurotrauma, 16, 617, 10.1089/neu.1999.16.617

Huang, 1997, Level of transforming growth factor β1 is elevated in cerebrospinal fluid of children with acute bacterial meningitis, J Neurol, 244, 634, 10.1007/s004150050159

De Groot, 1999, Expression of transforming growth factor (TGF)-β1, -β2, and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures, J Neuropathol Exp Neurol, 58, 174, 10.1097/00005072-199902000-00007

Peress, 1996, Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis, J Neuroimmunol, 71, 115, 10.1016/S0165-5728(96)00135-X

Vawter, 1996, TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid, Exp Neurol, 142, 313, 10.1006/exnr.1996.0200

Miyazawa, 2002, Two major Smad pathways in TGF-β superfamily signalling, Genes Cells, 7, 1191, 10.1046/j.1365-2443.2002.00599.x

Dhandapani, 2003, Transforming growth factor-β: a neuroprotective factor in cerebral ischemia, Cell Biochem Biophys, 39, 13, 10.1385/CBB:39:1:13

Buisson, 2003, Transforming growth factor-β and ischemic brain injury, Cell Mol Neurobiol, 23, 539, 10.1023/A:1025072013107

Boche, 2003, Transforming growth factor-β1-mediated neuroprotection against excitotoxic injury in vivo, J Cereb Blood Flow Metab, 23, 1174, 10.1097/01.WCB.0000090080.64176.44

Henrich-Noack, 1996, TGF-β1 protects hippocampal neurons against degeneration caused by transient global ischemia, Stroke, 27, 1609, 10.1161/01.STR.27.9.1609

Prehn, 1993, Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo, J Cereb Blood Flow Metab, 13, 521, 10.1038/jcbfm.1993.67

Brionne, 2003, Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain, Neuron, 40, 1133, 10.1016/S0896-6273(03)00766-9

Wyss-Coray, 1997, Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice, J Neuroimmunol, 77, 45, 10.1016/S0165-5728(97)00049-0

Wyss-Coray, 1997, Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease, Nature, 389, 603, 10.1038/39321

Wyss-Coray, 1995, Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1, Am J Pathol, 147, 53

Lesné, 2003, Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice, J Biol Chem, 278, 18408, 10.1074/jbc.M300819200

Burton, 2002, Transcriptional activation and increase in expression of Alzheimer's β-amyloid precursor protein gene is mediated by TGF-β in normal human astrocytes, Biochem Biophys Res Commun, 295, 702, 10.1016/S0006-291X(02)00724-6

Burton, 2002, Transforming growth factor-β-induced transcription of the Alzheimer β-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads, Biochem Biophys Res Commun, 295, 713, 10.1016/S0006-291X(02)00725-8

Johns, 1991, Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1, J Immunol, 147, 1792, 10.4049/jimmunol.147.6.1792

Amara, 1999, TGF-β1, regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization, Brain Res Mol Brain Res, 71, 42, 10.1016/S0169-328X(99)00158-8

Smith, 2005, Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes, Glia, 52, 209, 10.1002/glia.20236

Wang, 2007, Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex, Exp Neurol, 203, 168, 10.1016/j.expneurol.2006.08.006

da Cunha, 1993, Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex, J Neuroimmunol, 42, 71, 10.1016/0165-5728(93)90214-J

Vivien, 1998, Evidence of type I and type II transforming growth factor-β receptors in central nervous tissues: changes induced by focal cerebral ischemia, J Neurochem, 70, 2296, 10.1046/j.1471-4159.1998.70062296.x

Pratt, 1997, TGF-β in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases, Cytokine Growth Factor Rev, 8, 267, 10.1016/S1359-6101(97)00018-X

Flanders, 1998, Transforming growth factor-betas in neurodegenerative disease, Prog Neurobiol, 54, 71, 10.1016/S0301-0082(97)00066-X

König, 2005, TGF-β1 activates two distinct type I receptors in neurons: implications for neuronal NF-κB signaling, J Cell Biol, 168, 1077, 10.1083/jcb.200407027

Lux, 2006, ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-β and constitutively active receptor induced gene expression, BMC Cardiovasc Disord, 6, 13, 10.1186/1471-2261-6-13

Le, 2004, TGF-β1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways, J Immunol, 173, 962, 10.4049/jimmunol.173.2.962

Hamby, 2010, Smad3-dependent signaling underlies the TGF-β1-mediated enhancement in astrocytic iNOS expression, Glia, 58, 1282, 10.1002/glia.21005

Spooren, 2010, Cooperation of NFκB and CREB to induce synergistic IL-6 expression in astrocytes, Cell Signal, 22, 871, 10.1016/j.cellsig.2010.01.018

Fogal, 2008, Interleukin-1β: a bridge between inflammation and excitotoxicity?, J Neurochem, 106, 1, 10.1111/j.1471-4159.2008.05315.x

John, 2005, IL-1-regulated responses in astrocytes: Relevance to injury and recovery, Glia, 49, 161, 10.1002/glia.20109

Brambilla, 2005, Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury, J Exp Med, 202, 145, 10.1084/jem.20041918

Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-κB recruitment, Nat Immunol, 3, 69, 10.1038/ni748

Rahman, 2004, Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression, Biochem Pharmacol, 68, 1255, 10.1016/j.bcp.2004.05.042

Muegge, 2002, Preparing the target for the bullet, Nat Immunol, 3, 16, 10.1038/ni0102-16

Saccani, 2001, Two waves of nuclear factor κB recruitment to target promoters, J Exp Med, 193, 1351, 10.1084/jem.193.12.1351

Natoli, 2005, Interactions of NF-κB with chromatin: the art of being at the right place at the right time, Nat Immunol, 6, 439, 10.1038/ni1196

Ershler, 1994, The role of interleukin-6 in certain age-related diseases, Drugs Aging, 5, 358, 10.2165/00002512-199405050-00005

Taga, 1997, gp130 and the interleukin-6 family of cytokines, Annu Rev Immunol, 15, 797, 10.1146/annurev.immunol.15.1.797

Penkowa, 2003, Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury, Exp Neurol, 181, 130, 10.1016/S0014-4886(02)00051-1

Penkowa, 2003, Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide, J Neurosci Res, 73, 481, 10.1002/jnr.10681

Swartz, 2001, Interleukin-6 promotes post-traumatic healing in the central nervous system, Brain Res, 896, 86, 10.1016/S0006-8993(01)02013-3

Campbell, 1993, Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6, Proc Natl Acad Sci U S A, 90, 10061, 10.1073/pnas.90.21.10061

Quintana, 2009, Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis, J Immunol, 183, 2079, 10.4049/jimmunol.0900242

Sriram, 2004, J Biol Chem, 279, 19936, 10.1074/jbc.M309304200

Nakashima, 1999, Synergistic signaling in fetal brain by STAT3–Smad1 complex bridged by p300, Science, 284, 479, 10.1126/science.284.5413.479

Fan, 2005, DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling, Development, 132, 3345, 10.1242/dev.01912

Herrmann, 2008, STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury, J Neurosci, 28, 7231, 10.1523/JNEUROSCI.1709-08.2008

Su, 2010, Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation, Glia, 58, 901, 10.1002/glia.20972

Gong, 2008, Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-κB and JNK in LPS-treated microglia, J Neurochem, 107, 779, 10.1111/j.1471-4159.2008.05653.x

Levison, 2000, IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation, Glia, 32, 328, 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7

Gadea, 2008, Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway, J Neurosci, 28, 2394, 10.1523/JNEUROSCI.5652-07.2008

Khakh, 2006, P2X receptors as cell-surface ATP sensors in health and disease, Nature, 442, 527, 10.1038/nature04886

Bowser, 2007, Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes, J Gen Physiol, 129, 485, 10.1085/jgp.200709780

Halassa, 2009, Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior, Neuropharmacology, 57, 343, 10.1016/j.neuropharm.2009.06.031

Neary, 2004, Signaling from nucleotide receptors to protein kinase cascades in astrocytes, Neurochem Res, 29, 2037, 10.1007/s11064-004-6876-y

Neary, 2003, Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors, J Neurosci, 23, 2348, 10.1523/JNEUROSCI.23-06-02348.2003

Wanner, 2008, A new in vitro model of the glial scar inhibits axon growth, Glia, 56, 1691, 10.1002/glia.20721

Wang, 2004, P2X7 receptor inhibition improves recovery after spinal cord injury, Nat Med, 10, 821, 10.1038/nm1082

Peng, 2009, Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury, Proc Natl Acad Sci U S A, 106, 12489, 10.1073/pnas.0902531106

Urdinguio, 2009, Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies, Lancet Neurol, 8, 1056, 10.1016/S1474-4422(09)70262-5

Hamby, 2008, Transcriptional regulation of neuronal differentiation: the epigenetic layer of complexity, Biochim Biophys Acta, 1779, 432, 10.1016/j.bbagrm.2008.07.006

Camelo, 2005, Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis, J Neuroimmunol, 164, 10, 10.1016/j.jneuroim.2005.02.022

Kim, 2007, Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action, J Pharmacol Exp Ther, 321, 892, 10.1124/jpet.107.120188

Faraco, 2006, Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain, Mol Pharmacol, 70, 1876, 10.1124/mol.106.027912

Ren, 2004, Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction, J Neurochem, 89, 1358, 10.1111/j.1471-4159.2004.02406.x

Chen, 2006, Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes, Mol Psychiatry, 11, 1116, 10.1038/sj.mp.4001893

Faraco, 2009, Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo, Neurobiol Dis, 36, 269, 10.1016/j.nbd.2009.07.019

Suh, 2010, Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes, J Neuroimmune Pharmacol, 10.1007/s11481-010-9192-0

Morland, 2004, Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake, J Cereb Blood Flow Metab, 24, 1226, 10.1097/01.WCB.0000138666.25305.A7

Perisic, 2009, Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes, Neuropsychopharmacology, 35, 792, 10.1038/npp.2009.188

Trinka, 2007, The use of valproate and new antiepileptic drugs in status epilepticus, Epilepsia, 48, 49, 10.1111/j.1528-1167.2007.01349.x

Michaelis, 2007, Valproic acid as anti-cancer drug, Curr Pharm Des, 13, 3378, 10.2174/138161207782360528

Langley, 2005, Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents, Curr Drug Targets CNS Neurol Disord, 4, 41, 10.2174/1568007053005091

Kazantsev, 2008, Therapeutic application of histone deacetylase inhibitors for central nervous system disorders, Nat Rev Drug Discov, 7, 854, 10.1038/nrd2681

Balasubramanyam, 2004, Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription, J Biol Chem, 279, 51163, 10.1074/jbc.M409024200

Marcu, 2006, Curcumin is an inhibitor of p300 histone acetyltransferase, Med Chem, 2, 169, 10.2174/157340606776056133

Natarajan, 2002, Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes, J Immunol, 168, 6506, 10.4049/jimmunol.168.12.6506

Laird, 2010, Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?, J Neurochem, 113, 637, 10.1111/j.1471-4159.2010.06630.x

Lin, 2010, Curcumin provides neuroprotection after spinal cord injury, J Surg Res

Zador, 2007, Aquaporins: role in cerebral edema and brain water balance, Prog Brain Res, 161, 185, 10.1016/S0079-6123(06)61012-1

Kim, 2010, Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia, J Cereb Blood Flow Metab, 30, 943, 10.1038/jcbfm.2009.260

Filippidis, 2010, Hydrocephalus and aquaporins: lessons learned from the bench, Childs Nerv Syst

Benarroch, 2005, Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system, Mayo Clinic Proceedings, 80, 1326, 10.4065/80.10.1326

Nag, 2009, Pathology and new players in the pathogenesis of brain edema, Acta Neuropathologica, 118, 197, 10.1007/s00401-009-0541-0

Lennon, 2005, IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, J Exp Med, 202, 473, 10.1084/jem.20050304

Hinson, 2010, Neurological autoimmunity targeting aquaporin-4, Neuroscience, 168, 1009, 10.1016/j.neuroscience.2009.08.032

Roemer, 2007, Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis, Brain, 130, 1194, 10.1093/brain/awl371

Hu, 2009, The pathological spectrum of CNS inflammatory demyelinating diseases, Semin Immunopathol, 31, 439, 10.1007/s00281-009-0178-z

Sharma, 2010, Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination, Acta Neuropathol, 120, 223, 10.1007/s00401-010-0704-z

Voskuhl, 2001, Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis, Neuroscientist, 7, 258, 10.1177/107385840100700310

Orthmann-Murphy, 2008, Gap junctions couple astrocytes and oligodendrocytes, J Mol Neurosci, 35, 101, 10.1007/s12031-007-9027-5

Dermietzel, 1991, Gap junctions between cultured astrocytes: immunocytochemical, molecular, and electrophysiological analysis, J Neurosci, 11, 1421, 10.1523/JNEUROSCI.11-05-01421.1991

Duffy, 2000, Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1β in primary human fetal astrocytes, J Neurosci, 20, RC114, 10.1523/JNEUROSCI.20-23-j0004.2000

Blomstrand, 1999, Extent of intercellular calcium wave propagation is related to gap junction permeability and level of connexin-43 expression in astrocytes in primary cultures from four brain regions, Neuroscience, 92, 255, 10.1016/S0306-4522(98)00738-6

Giaume, 2010, Astroglial networks: a step further in neuroglial and gliovascular interactions, Nat Rev Neurosci, 11, 87, 10.1038/nrn2757

Rouach, 2002, Gap junctions and connexin expression in the normal and pathological central nervous system, Biol Cell, 94, 457, 10.1016/S0248-4900(02)00016-3

Kielian, 2008, Glial connexins and gap junctions in CNS inflammation and disease, J Neurochem, 106, 1000, 10.1111/j.1471-4159.2008.05405.x

Olsen, 2008, Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation, J Neurochem, 107, 589, 10.1111/j.1471-4159.2008.05615.x

Mori, 2006, Arundic acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice, J Pharmacol Exp Ther, 318, 571, 10.1124/jpet.106.105171

Oki, 2008, Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice, Cell Mol Neurobiol, 28, 417, 10.1007/s10571-007-9241-2

Tateishi, 2002, Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats, J Cereb Blood Flow Metab, 22, 723, 10.1097/00004647-200206000-00011

Behrstock, 2008, Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF, Cell Transplant, 17, 753, 10.3727/096368908786516819

Suzuki, 2007, GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS, PLoS One, 2, e689, 10.1371/journal.pone.0000689